Abeona Therapeutics Inc.

NASDAQ: ABEOHealthcare / Biotechnology / USA
4.43-0.1900-4.11%Vol 856 3401Y Perf -72.96%
Jun 24th, 2019 16:00
BID4.42 ASK4.43
Open4.73 Previous Close4.62
Pre-Market4.62 After-Trading4.43
 - -%  - -%
Target Price
23.88 
Analyst Rating
Strong Buy 1.00
Potencial %
439.05 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)218 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
0.23 
Earnings Date
8th Aug 2019

Today's Price Range

4.404.73

52wk Range

4.4017.25

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-32.37%
3 Months
-41.01%
6 Months
-30.78%
1 Year
-72.96%
3 Years
73.05%
5 Years
-71.42%

Name / TickerPriceChg.Chg.%
ABEO4.43-0.1900-4.11
AAPL198.58-0.2000-0.10
GOOG1 115.52-6.3600-0.57
MSFT137.780.81000.59
XOM76.95-0.7400-0.95
WFC46.27-0.6200-1.32
JNJ143.060.97000.68
FB192.601.46000.76
GE10.28-0.2000-1.91
JPM108.66-0.7800-0.71
Earnings HistoryEstimateReportedSurprise %
Q01 2019-0.31-0.39-25.81
Q04 2018-0.42-0.3614.29
Q03 2018-0.23-0.34-47.83
Q02 2018-0.16-0.25-56.25
Q01 2018-0.19-0.185.26
Q04 2017-0.13-0.19-46.15
Q03 2017-0.18-0.1327.78
Q02 2017-0.13-0.21-61.54
Earnings Per EndEstimateRevision %Trend
6/2019 QR-0.39-14.71Negative
9/2019 QR-0.39-11.43Negative
12/2019 FY-1.60-8.84Negative
12/2020 FY-1.662.35Positive
Next Report Date8th Aug 2019
Estimated EPS Next Report-0.39
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume856 340
Shares Outstanding (in ths.)49 162
Trades Count3 509
Dollar Volume3 322 146
Avg. Volume437 914
Avg. Weekly Volume1 095 829
Avg. Monthly Volume670 357
Avg. Quarterly Volume468 063
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (100.00 %)
8 (100.00 %)
8 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. The gene therapy involves the use of DNA as a potential therapy to treat a disease. The company's initial programs are focused on lysosomal storage diseases such as Mucopolysaccharidosis (MPS) IIIA and IIIB. It is also developing ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten Disease, respectively, ABO-401 for the treatment of cystic fibrosis, and ABO-5OX for the treatment of retinal diseases.

CEO: Joao Siffert

Teplephone: +1 646 813-4712

Address: 1330 Avenue of the Americas, New York 10019, NY, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

46%54%

Bearish Bullish

42%58%

Bearish Bullish

65%35%

News